LUMITO TO3 — Lumito AB (publ) Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- SEK138.00m
- SEK135.79m
- SEK0.10m
Annual income statement for Lumito AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0.099 |
| Cost of Revenue | |||||
| Gross Profit | — | 8.73 | 14.3 | 13.9 | 4.13 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 16.1 | 26.4 | 27.3 | 26.5 | 38.4 |
| Operating Profit | -16.1 | -26.4 | -27.3 | -26.5 | -38.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -16 | -26.4 | -27 | -25.8 | -41.6 |
| Net Income After Taxes | -16 | -26.4 | -27 | -25.8 | -41.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -16 | -26.4 | -27 | -25.8 | -41.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -16 | -26.4 | -27 | -25.8 | -41.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.157 | -0.304 | -0.158 | -0.125 | -0.165 |
| Dividends per Share |